(Q33342218)

English

Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I study

scientific article

Statements

Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I study (English)
Charlotte van Kesteren
Michel J X Hillebrand

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit